A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection

Hepatology

Volumn 26, Issue 4, 1997, Pages 853-857

  Barnes, David ^a   Talenti, David ^a,b   Cammell, Gregory ^a   Goormastic, Marlene ^a   Farquhar, Lou ^a   Henderson, Michael ^a   Vogt, David ^a   Mayes, James ^a   Westveer, Mary Kay ^a   Carey, William ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b GUTHRIE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; LIVER ENZYME; METHYLPREDNISOLONE; OKT 3; PREDNISONE; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; GRAFT REJECTION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

EID: 12644250099     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260408     Document Type: Article

References (20)

1. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-1115.
2. Colonna J, Goldstein L, Brems J, Vargas J, Brill J, Berquist W, Hiatt J, et al. A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection. Arch Surg 1987;122:1120-1123.
3. Solomon H, Gonwa T, Mor E, Holman M, Gibbs J, Watemberg I, Netto G, et al. OKT3 rescue for steroid-resistant rejection in adult liver transplantation. Transplantation 1993;55:87-91.
4. Nozaki H. Experimental study on the effect of ursodeoxycholic acid in liver transplantation. J Jpn Surg Soc 1992;93:1481-1488.
5. Persson H. Friman S, Schersten T, Svanvik J, Karlberg I. Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients. Lancet 1990;336:52-53.
6. Friman S, Persson H, Schersten T, Svanvik J, Karlberg I. Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation. Transplantation Proc 1992;24:389-390.
7. Sharara AI, Camargo CA, Clavien PA. Ursodeoxycholic acid prevents steroid resistant rejection in liver transplant recipients. Gastroenterology. 1995;108:A1168.
8. Cirillo N. Zwas, F. Ursodeoxycholic acid in the treatment of chronic liver disease. Am J Gastroenterol 1994;89:1447-1452.
9. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey R, Blendis L, Ghent C, Michieletti P, et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. HEPATOLOGY 1994;19:1149-1156.
10. Poupon R, Poupon R, Balkau B, and the UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-1347.
11. Lindor K, Dickson ER, Baldus W, Jorgensen R, Ludwig J, Murtaugh P, Harrison J, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284-1290.
12. Combes B, Carithers R, Maddrey W, Lin D, McDonald M, Wheeler D, Eigenbrodt E, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. HEPATOLOGY 1995;22:759-766.
13. Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. HEPATOLOGY 1990;11: 12-15.
14. Terasaki S, Nakanuma Y, Ogino H, Unoura M, Kobayashi K. Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy. Am J Gastroenterol 1991; 86:1194-1199.
15. International Working Party. Terminology for hepatic allograft rejection. HEPATOLOGY 1995;22:648-654.
16. Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bull 1945;1:80-83.
17. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
18. Peto R, Peto J. Assymptotically efficient rank invariant test procedures. J Royal Stat Soc Ser 1972;A135:185-198.
19. Al-Quaiz M, O'Grady J, Tredger J, Williams R. Variable effect of ursodeoxycholic acid on cyclosporin absorption after orthotopic liver transplantation. Transplant Int 1994;7:190-194.
20. Pageaux G, Blanc P, Perrigault P. Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation. J Hepatol 1995;23:119-122.